Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.

Syed S MahmoodPeter A RiedellStephanie FeldmanGina GeorgeStephen A SansoterraThomas AlthausMahin RehmanElena MeadJennifer E LiuRichard B DevereuxJonathan W WeinsaftJiwon KimLauren BalkanTarek BarbarKatherine Lee ChuyBhisham HarchandaniMiguel-Angel PeralesMark B GeyerJae H ParkM Lia PalombaRoni ShouvalAna A TomasGunjan L ShahEric H YangDaria L GautMichael V RothbergEvelyn M HornJohn P LeonardKoen Van BesienMatthew J FrigaultZhengming ChenBhoomi MehrotraTomas G NeilanRichard M Steingart

Published in: European heart journal (2023)

Chimeric antigen receptor T-cell therapy recipients who experience SCE have higher overall mortality and NRM and higher peak levels of IL-6, CRP, ferritin, and troponin.

Keyphrases

kidney transplantation
type diabetes
stem cells
bone marrow
replacement therapy
smoking cessation